Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

66.13
-0.8700-1.30%
Post-market: 66.130.00000.00%16:57 EDT
Volume:1.04M
Turnover:68.76M
Market Cap:5.47B
PE:8.50
High:67.60
Open:67.43
Low:65.80
Close:67.00
52wk High:87.50
52wk Low:35.95
Shares:82.77M
Float Shares:72.98M
Volume Ratio:0.93
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.78
EPS(LYR):7.78
ROE:-7740.12%
ROA:23.26%
PB:-26.66
PE(LYR):8.50

Loading ...

PTC Therapeutics: Sephience Uptake, Advancing Pipeline, and Strengthening Financials Support Buy Rating

TIPRANKS
·
Feb 20

U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler

Reuters
·
Feb 20

PTC Therapeutics Inc : RBC Cuts Target Price to $82 From $87

THOMSON REUTERS
·
Feb 20

PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Disposes of Common Shares

Reuters
·
Feb 20

Earnings Flash (PTCT) PTC Therapeutics Posts Q4 Loss $1.67 per Share

MT Newswires Live
·
Feb 20

PTC Therapeutics Inc. Publishes Corporate Presentation Highlighting Sephience Launch and Pipeline Progress

Reuters
·
Feb 20

PTC Therapeutics reports Q4 EPS ($1.67), consensus (41c)

TIPRANKS
·
Feb 20

PTC Therapeutics sees 2026 product revenue up 19%-36%to $700M-$800M

TIPRANKS
·
Feb 20

PTC Therapeutics Q4 EPS $(1.67) Misses $0.07 Estimate, Sales $164.677M Miss $276.665M Estimate

Benzinga
·
Feb 20

PTC Therapeutics posts FY 2025 total revenues of USD 1.73B**2.15x**

Reuters
·
Feb 20

BRIEF-PTC Therapeutics Q4 Net Income USD -134.965 Million

Reuters
·
Feb 20

PTC Therapeutics Faces Translarna Setback While Valuation Signals Potential Upside

Simply Wall St.
·
Feb 18

TD Cowen Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
Feb 13

BUZZ-PTC Therapeutics falls after withdrawing muscle disorder drug marketing application

Reuters
·
Feb 13

PTC Therapeutics Withdraws Translarna NDA After FDA Feedback

TIPRANKS
·
Feb 13

PTC Therapeutics Inc - Withdraws Nda Resubmission for Translarna

THOMSON REUTERS
·
Feb 13

PTC Therapeutics Provides Regulatory Update on Translarna™

THOMSON REUTERS
·
Feb 13

PTC Therapeutics Inc - Withdrawal Following FDA Feedback on Application Review

THOMSON REUTERS
·
Feb 13

Earning Preview: PTC Therapeutics Q4 revenue is expected to increase by 19.03%, and institutional views are to be added

Earnings Agent
·
Feb 12

PTC Therapeutics Inc. to Report Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Feb 05